Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Piskol

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
Cancer Immunology, Immunotherapy : CII|August 7, 2024
NKG2D-bispecific enhances NK and CD8+ T cell antitumor immunityAurelie Herault, Judy Mak, Josefa de la Cruz-Chuh, et al.
Translational Vision Science & Technology|October 18, 2022
Direct Tie2 Agonists Stabilize Vasculature for the Treatment of Diabetic Macular EdemaNicholas J Agard, Gu Zhang, John Ridgeway, et al.
Nature|October 13, 2017
Dynamic landscape and regulation of RNA editing in mammalsMeng How Tan, Qin Li, Raghuvaran Shanmugam, et al.
Nature|May 6, 2021
ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanomaIvana Yen, Frances Shanahan, Jeeyun Lee, et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
Cancer Immunology, Immunotherapy : CII|August 7, 2024
NKG2D-bispecific enhances NK and CD8+ T cell antitumor immunityAurelie Herault, Judy Mak, Josefa de la Cruz-Chuh, et al.
Translational Vision Science & Technology|October 18, 2022
Direct Tie2 Agonists Stabilize Vasculature for the Treatment of Diabetic Macular EdemaNicholas J Agard, Gu Zhang, John Ridgeway, et al.
Nature|October 13, 2017
Dynamic landscape and regulation of RNA editing in mammalsMeng How Tan, Qin Li, Raghuvaran Shanmugam, et al.
Nature|May 6, 2021
ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanomaIvana Yen, Frances Shanahan, Jeeyun Lee, et al.
Pageof 5